Oralair

Allergen Extract From Pollen Of Dactylis Glomerata, Anthoxanthum Odoratum, Lolium Perenne, Poa Prate, the active ingredient in Oralair, is a allergen immunotherapy presented as a for sublingual use. It treats allergic rhinitis caused by grass pollen in children and adults. GNH USA supplies Oralair as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oralair as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oralair is a sub‑lingual allergen immunotherapy that targets the allergic response pathway associated with grass‑pollen allergy.

- Seasonal grass pollen allergy: reduces the severity and frequency of nasal symptoms and improves quality of life. - Allergic rhinitis: decreases the need for rescue antihistamine medication through immunologic desensitisation of the patient . - Long‑term allergy pro‑   g ​   ". -  ".